|Study Description:||The goal of this clinical research study is find the highest tolerable dose of |
romidepsin that can be given in combination with ifosfamide, carboplatin,
etoposide (ICE) to patients with PTCL. The safety of this drug combination will
also be studied.
Romidepsin is designed to stop the growth of cancer cells and block new blood
vessels from forming around the cancer cells. This may cause the cancer cells
Ifosfamide and etoposide are designed to slow or stop the growth of cancer
Carboplatin is designed to interfere with the growth of cancer cells by
stopping cell division, which may cause the cells to die.